tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Jonathan Lee, 47 are a BUY (79.66%), 12 are a HOLD (20.34%).
Analyst Jonathan Lee, currently employed at GUGGENHEIM, carries an average stock price target met ratio of 45.44% that have a potential upside of 22.46% achieved within 97 days.
Jonathan Lee’s has documented 109 price targets and ratings displayed on 9 stocks. The coverage is on Technology, Healthcare sectors.
Most recent stock forecast was given on ACN, Accenture plc at 02-Oct-2026.
Analyst best performing recommendations are on PTCT (PTC THERAPEUTICS).
The best stock recommendation documented was for ACN (ACCENTURE PLC) at 6/22/2026. The price target of $185 was fulfilled within 60 days with a profit of $61.65 (49.98%) receiving and performance score of 8.33.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 21-Mar-2025
$252
$11.74 (4.89%)
$265
Hold Since 26-Jun-2026
$201
$-39.26 (-16.34%)
$173
9 days ago
(15-Oct-2026)
36/52 (69.23%)
$-23.92 (-10.63%)
242
Hold Since 21-Jun-2024
$230
$-10.26 (-4.27%)
$210
9 days ago
(15-Oct-2026)
20/22 (90.91%)
$5.08 (2.26%)
199
Buy Since 29-Jan-2024
$241
$0.74 (0.31%)
$226
18 days ago
(06-Oct-2026)
4/15 (26.67%)
$47.6 (24.61%)
124
Buy Since 22-Jun-2026
$240
$-0.26 (-0.11%)
$175
22 days ago
(02-Oct-2026)
2/2 (100%)
$41.1 (20.66%)
33
Which stock is Jonathan Lee most bullish on?
Which stock is Jonathan Lee most reserved on?
What Year was the first public recommendation made by Jonathan Lee?
